Cleared Traditional

K213649 - BodyTom 64

K213649 is an FDA 510(k) clearance for BodyTom 64, manufactured by Neurologica Corporation. The device is a Class 2 Radiology device with product code JAK cleared through the Traditional 510(k) pathway after a 161-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2022
Decision
161d
Days
Class 2
Risk

K213649 is an FDA 510(k) clearance for the BodyTom 64. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Neurologica Corporation (Danvers, US). The FDA issued a Cleared decision on April 29, 2022 after a review of 161 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neurologica Corporation devices

FDA 510(k) Submission Details - K213649

510(k) Number K213649 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 19, 2021
Decision Date April 29, 2022
Days to Decision 161 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d slower than avg
Panel avg: 107d · This submission: 161d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAK Device Classification - Class 2, Special Controls

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 639
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K213649.
XACT ACE Robotic System
K221116 · Xact Robotics, Ltd. · May 2022
NewTom 7G
K220664 · Cefla S.C. · May 2022
Liver Suite
K211180 · GE Medical Systems SCS · May 2022
Philips Incisive CT
K212441 · Philips Healthcare (Suzhou) Co., Ltd. · Apr 2022
HealthOST
K213944 · Nanoxai , Ltd. · Apr 2022
Syngo.CT Dual Energy
K212889 · Siemens Medical Solutions USA, Inc. · Mar 2022